4. Goals of Asthma Therapy and Management

The EPR4 and GINA reports are widely available for review. In this reference guide, we will only highlight the key aspects of these guidelines.

EPR-4 Update report

GINA 2020 report

Key components of therapy reviewed in the EPR:

Assessing (diagnosing) and monitoring asthma severity
Education for a partnership in care
Environmental and comorbidity control
Medication management

The EPR recommendations on asthma emphasize diagnosis and assessment of asthma severity on the first visit, with subsequent visits being focused on titration of medications based on asthma control.

EPR3 figure for asthma management and care

EPR 4 provided updated guidance on 6 priority topics in asthma care:

Fractional exhaled nitric oxide (FeNO)
Indoor allergen mitigation
Intermittent inhaled corticosteroids
Long-acting muscarinic antagonists (LAMA)
Immunotherapy in the treatment of allergic asthma
Bronchial Thermoplasty

GINA Cycle for Personalized Asthma Management:

The GINA recommendations for personalized asthma management emphasize asthma management as a continued cycle of reviewing, assessing, and adjusting asthma treatments throughout the lifespan of a patient. Of note, unlike the EPR, the diagnosis of asthma may be done at the first visit, but the severity of asthma is defined by the level of medication to obtain good asthma control.

Figure for personalized asthma management for all age groups from GINA2020

4. Goals of Asthma Therapy and Management

Key components of therapy reviewed in the EPR:

EPR 4 provided updated guidance on 6 priority topics in asthma care:

GINA Cycle for Personalized Asthma Management:

Built for kids.®